Condition: Oligometastasis · Lung Cancer · Colo-rectal Cancer · Sponsor: Roswell Park Cancer Institute
This protocol is comprised of three unblinded, randomized, single-center studies to evaluate the impact of immediate versus three-month delayed comprehensive ablative treatment on survival in newly diagnosed metastatic patients with lung (Trial 1), colorectal (Trial 2), and prostate (Trial 3) cancers
This description comes directly from the study's public registry record.
ASK RPCI · 1-800-767-9355 · askroswellpark@roswellpark.org
Always discuss trial participation with your own doctor first.
| Roswell Park Comprehensive Cancer Center | Buffalo, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06563388